Blast X donation is one of several to long-term care facilities to effectively treat chronic wounds
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Next Science (ASX:NXS), an innovative medical technology company that is the leader in treating biofilm-based infections in humans, announced today that it has donated $300,000 worth of BlastX� Antimicrobial Wound Gel to Hampton Ridge Healthcare and Rehabilitation in Toms River, New Jersey. This gift is part of a $500,000 donation program with 3M Company, the exclusive distributor of BlastX�, that helps caregivers treat patients suffering from chronic wounds at nursing and rehabilitative care facilities.
�Wound care is crucial for patients in long-term care facilities, particularly for aging patients,� said Dustin Haines, chief commercial officer for Next Science. �This donation is one way we can help frontline caregivers provide the best treatment possible and deliver on our mission to heal people and save lives with our innovative technologies.�
The support to Hampton Ridge is the latest of several donations of BlastX� that Next Science and 3M will make to long-term care facilities. Previously, the company set up donation programs to help patients who were unable to receive treatment at wound care clinics that were closed as a result of COVID-19.
�With Next Science�s BlastX� gel, we can be sure patients receive the best care possible to treat chronic wounds and mitigate infection by preventing bacterial resistance,� said Dr. Matthew Regulski, DPM, a surgeon who regularly treats patients at Hampton Ridge Healthcare and Rehabilitation. �We are grateful to Next Science and their generous support in treating current and future patients at our facility.�
BlastX� is a breakthrough antimicrobial wound gel that is powered by Next Science�s patented, non-toxic, biofilm-disruption Xbio� technology. BlastX� breaks down biofilm, destroys bacteria within the gel and defends against reinfection.
Biofilm, which is a naturally occurring substance, accounts for a significant percentage of hard-to-manage bacterial proliferations worldwide. The Centers for Disease Control and Prevention estimate that 80% of infections in humans are located in biofilm. In the U.S., these infections contribute to approximately 500,000 deaths each year and cost an estimated $94 billion to treat.
About Next Science
Next Science is a medical technology company headquartered in Sydney, Australia, with a research and development center based in Jacksonville, Florida. Established in 2012, the company�s primary focus is on the development and continued commercialization of its proprietary Xbio� technology to reduce the impact of biofilm-based infections in human health. Xbio� is a unique, non-toxic technology with proven efficacy in eradicating both biofilm based and free-floating bacteria. Next Science owns 100% of the patent protected intellectual property relating to its Xbio� technology. For further information visit: www.nextscience.com.
About Hampton Ridge Healthcare and Rehabilitation
Hampton Ridge Healthcare and Rehabilitation is one of New Jersey�s premier centers for skilled nursing and rehabilitative care. Hampton Ridge is a comprehensive nursing care facility, providing a full range of healthcare services, including rehabilitative therapy, skilled nursing care, post-surgical care, long-term care, Alzheimer�s and dementia care, as well as respite and palliative care. Hampton Ridge offers outstanding healthcare in a comfortable and pleasant environment with beautiful accommodations and fine amenities. The facility is located in Tom River. For further information visit: https://hamptonridgehealth.com.
About 3M
At 3M, we apply science in collaborative ways that improve lives daily. With $32 billion in sales, our 96,000 employees connect with customers all around the world. Learn more about 3M�s creative solutions to the world�s problems at http://www.3m.com/ or on Twitter @3M or @3MNews.
Contacts
Media Contact
Anthony Priwer
Dalton Agency
(615) 515-4891
[email protected]
